Roles of cyclin-dependent kinase 8 and β-catenin in the oncogenesis and progression of gastric adenocarcinoma

International Journal of Oncology

Volumn 38, Issue 5, 2011, Pages 1375-1383

  Kim, Mun Young ^a   Han, Song Iy ^a   Lim, Sung Chul ^a  

^a Chosun University College of Medicine   (South Korea)

Author keywords

catenin; Adenocarcinoma; Cyclin dependent kinase 8; Cyclin dependent kinase 8 interference; Stomach

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE 8;

ADENOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CYCLIN-DEPENDENT KINASE 8; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 79955034418     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.948     Document Type: Article

References (29)

1. Hohenberger P and Gretschel S: Gastric cancer. Lancet 362: 305-315, 2003. (Pubitemid 36936845)
2. Plummer M, Franceschi S and Muñoz N: Epidemiology of gastric cancer. IARC Sci Publ 157: 311-326, 2004.
3. Headquarters of Korea Central Cancer Registry: Cancer Registry System in Korea. http://ncc.re.kr/index.jsp.
4. Becker KF, Keller G and Hoefler H: The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 9: 5-11, 2000.
5. Panani AD: Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett 266: 99-115, 2008.
6. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I and Kerr D: Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499, 2009.
7. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B and Kinzler KW: APC mutations occur early during colorectal tumorigenesis. Nature 359: 235-237, 1992.
8. Zhang H and Xue Y: Wnt pathway is involved in advanced gastric carcinoma. Hepatogastroenterology 55: 1126-1130, 2008. (Pubitemid 351976001)
9. Kim B, Byun SJ, Kim YA, Kim JE, Lee BL, Kim WH and Chang MS: Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Pathology 42: 58-65, 2010.
10. Firestein R and Hahn WC: Revving the Throttle on an oncogene: CDK8 takes the driver seat. Cancer Res 69: 7899-7901, 2009.
11. Kim S, Xu X, Hecht A and Boyer TG: Mediator is a transducer of Wnt/beta-catenin signaling. J Biol Chem 281: 14066-14075, 2006.
12. Firestein R, Bass AJ, Kim SY, et al: CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455: 547-551, 2008.
13. Morris EJ, Ji JY, Yang F, et al: E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 455: 552-556, 2008.
14. Greene FL, Page DL and Fleming ID: AJCC cancer staging manual. 6th edition. Springer-Verlag, New York, 2002.
15. Kawasaki T, Nosho K, Ohnishi M, et al: Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer. Neoplasia 9: 569-577, 2007. (Pubitemid 47121831)
16. Yonemura Y, Endou Y, Kimura K, et al: Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 6: 4234-4242, 2000.
17. Flatmark K, Pedersen KB, Nesland JM, et al: Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer. J Pathol 200: 589-895, 2003.
18. Kikuchi N, Horiuchi A, Osada R, Imai T, Wang C, Chen Xand Konishi I: Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: an important autocrine/paracrine factor in tumor progression. Cancer Sci 97: 1061-1069, 2006. (Pubitemid 44322555)
19. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991.
20. Ozawa M, Baribault H and Kemler R: The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8: 1711-1717, 1989. (Pubitemid 19273986)
21. Kimura K, Endo Y, Yonemura Y, Heizmann CW, Schafer BW, Watanabe Y and Sasaki T: Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 16: 1125-1131, 2000.
22. Stein U, Arlt F, Walther W, et al: The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology 131: 1486-1500, 2006. (Pubitemid 44708942)
23. Senderowicz AM and Sausville EA: Preclinical and clinical development of cyclin-dependent kinase modulators. J Natl Cancer Inst 92: 376-387, 2000. (Pubitemid 30154819)
24. Arguello F, Alexander M, Sterry JA, et al: Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity in vivo against human leukemia and lymphoma xenografts. Blood 91: 2482-2490, 1998. (Pubitemid 28155524)
25. Zhai S, Senderowicz AM, Sausville EA and Figg WD: Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development. Ann Pharmacother 36: 905-911, 2002. (Pubitemid 34517422)
26. Senderowicz AM: Small-molecule cyclin-dependent kinase modulators. Oncogene 42: 6609-6620, 2003.
27. Casamassimi A and Napoli C: Mediator complexes and eukaryotic transcription regulation: an overview. Biochimie 89: 1439-1446, 2007. (Pubitemid 350122855)
28. Gold MO and Rice AP: Targeting of CDK8 to a promoter proximal RNA element demonstrates catalysis dependent activation of gene expression. Nucleic Acids Res 26: 3784-3788, 1998. (Pubitemid 28367986)
29. Seo JO, Han SI and Lim SC: Role of CDK8 and ß-catenin in colorectal adenocarcinoma. Oncol Rep 24: 285-291, 2010.